Skip to main content
. 2019 Oct 23;122(6):2591–2600. doi: 10.1152/jn.00542.2019

Table 1.

Study participant clinical and demographic characteristics

Total Cohort Rs6795970 Homozygote Heterozygote and Wild Type P Value
n 166 27 139
Age, yr 61.5 ± 1.0 61 ± 2.6 61.6 ± 1.1 0.89
Sex, female/male 104/62 17/10 87/52 0.99
Body weight, kg 83 ± 1.7 88 ± 4.2 83 ± 1.9 0.25
Body mass index, kg/m2 29.4 ± 0.5 29.4 ± 1.3 29.5 ± 0.6 0.81
Race/Ethnicity 164 White,
2 Hispanic
27 White 137 White,
2 Hispanic
0.99
Active tobacco use, yes/no 32/134 4/23 28/111 0.61
Active alcohol use, yes/no 92/74 17/10 75/64 0.41
Opiate before surgery, yes/no 10/156 2/25 8/131 0.67
NSAID before surgery, yes/no 60/106 12/15 48/91 0.38
Other pain medication use before surgery, yes/no 63/103 10/17 53/86 0.99
Surgery type, laparoscopic/open 116/50 19/8 97/42 0.99
Intraoperative opiate use (morphine equivalent), mg 26.8 ± 0.9 28.1 ± 2.5 26.6 ± 1.0 0.48
Intraoperative opiate use normalized to body weight, mg/kg 0.34 ± 0.01 0.33 ± 0.03 0.34 ± 0.01 0.85
Postoperative (24 h) opiate use normalized to body weight, mg/kg 0.83 ± 0.05 0.65 ± 0.09 0.86 ± 0.06 0.12

Values are means ± SE or number of patients with the indicated characteristic.